Ibere Pharmaceuticals Price (IBER)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

No Data


Table Charts
Bar Charts

Revenue and Profitability

Year 2020 2021
Revenue - 0
Net Income - 1,561,747
FCF USD - -868,746
OCF USD - -868,746

Financial Health - DEBT

Year 2020 2021
YTPD - 0.00
D/E 8.78 0.00
CA/CL 0.27 1.86
TA/TL 1.03 12.02
Total Debt 169,000 0

Management Performance

Year 2020 2021
ROIC - -0.80%
ROE - 1.23%
ROA - 1.13%
NM % - -
FCF / R% - 0.00%
FCF / NI% - -55.63%
Operating Margin (OM) - -

Per Share

Year 2020 2021
EPS 0.00 0.11
SPS 0.00 0.00
OCPS 0.00 -0.06
FCPS 0.00 -0.06
BVPS 0.00 8.55

Per Share - CAGR

Year 2020 2021
CAGR-EPS 0.00 0.11
CAGR-SPS 0.00 0.00
CAGR-OCPS 0.00 -0.06
CAGR-FCPS 0.00 -0.06
CAGR-BVPS 0.00 8.55
Revenue $0.00
3Y
5Y
7Y
10Y
Net Income $1.56M
3Y
5Y
7Y
10Y
Operating Cash Flow $-868,746.00
3Y
5Y
7Y
10Y
Free Cash Flow $-868,746.00
3Y
5Y
7Y
10Y
YTPD $0.00
3Y
5Y
7Y
10Y
D/E $0.00
3Y
5Y
7Y
10Y
CA/CL $1.86
3Y
5Y
7Y
10Y
TA/TL $12.02
3Y
5Y
7Y
10Y
ROIC $-0.80%
3Y
5Y
7Y
10Y
ROE $1.23%
3Y
5Y
7Y
10Y
ROA $1.13%
3Y
5Y
7Y
10Y
Net Margin $0.00%
3Y
5Y
7Y
10Y
FCF / R% $0.00%
3Y
5Y
7Y
10Y
FCFNI % $-55.63%
3Y
5Y
7Y
10Y
Operating Margin $0.00
3Y
5Y
7Y
10Y
EPS $0.11
3Y
5Y
7Y
10Y
SPS $0.00
3Y
5Y
7Y
10Y
OCPS $-0.06
3Y
5Y
7Y
10Y
FCPS $-0.06
3Y
5Y
7Y
10Y
BVPS $8.55
3Y
5Y
7Y
10Y
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation